Alteration of estrogen-regulated gene expression in human cells induced by the agricultural and horticultural herbicide glyphosate

Human and Experimental Toxicology

Volumn 26, Issue 9, 2007, Pages 747-752

  Hokanson, R ^a   Fudge, R ^a   Chowdhary, R ^a   Busbee, David L ^a,b  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

Agricultural chemicals; DNA microarray analysis; Gene expression; Glyphosate herbicide; Real time quantitative PCR

Indexed keywords

AGRICULTURAL CHEMICAL; ESTROGEN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYPHOSATE; HERBICIDE; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1;

ARTICLE; CELL STRAIN MCF 7; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION; GENE MUTATION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

BREAST NEOPLASMS; CELL LINE, TUMOR; ESTRADIOL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCINE; HERBICIDES; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; RISK ASSESSMENT;

MAMMALIA;

EID: 36348936096     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1177/0960327107083453     Document Type: Article

References (38)

1. Bradberry SM, Proudfoot AT, Vale JA. Glyphosate Poisoning. Toxicol Rev 2004; 23(3): 159-67.
2. Steinrucker HC, Amrhein N. The herbicide glyphosate is a potent inhibitor of 5-enolpyruvl-shikimic acid-3phosphate synthase. Biochem Biophys Res Commun 1980; 94: 1207-12.
3. Williams GM, Kroes R, Munro IC. Safety evaluation and risk assessment of the herbicide 'Roundup' and its active ingredient, glyphosate, for humans. Regul Toxicol Pharmacol 2000; 31: 117-65.
4. Environ Health Criteria #159.
5. Hori Y, Fujisawa M, Shimada K. Determination of the herbicide glyphosate and its metabolite in biological specimens by gas chromatographiy-maqss spectrometry: a case of poisoning by Roundup™ herbicide. J Anal Toxicol 2003; 27: 162-6.
6. Gray LE Jr, Ostby J, Furr J, Price M, Veeramachaneni DNR, Parks L. Perinatal exposure to the phthalates DEHP, BBP, and DINP, but not DEP, DMP, or DOTP, alters sexual differentiation of the male rat. Toxicol Sci 2000; 58: 350-65.
7. Fuller, P. The steroid receptor superfamily: mechanisms of diversity. FASEB J 1991; 5: 3092-9.
8. O'Malley B, Tsai M-J. Molecular pathways of steroid receptor action. Biol Repro 1992; 46; 163-7.
9. Truss M, Beato M. Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endocrinol Rev 1993; 14(4): 450-79.
10. Lieberman, BA. The estrogen receptor activity cycle: dependence on multiple protein-protein interaction. Crit Rec In Endocr Gene Expr 1997; 7: 43-59.
11. Safe S 2,3,7,8-Tetrachlorodibenzo-p-dioxin, and related halogenated aromatic hydrocarbons: examination of mechanisms of toxicity. Toxicol 1990; 21(1): 51-88.
12. Jackson TF, Haibert FL. A toxic syndrome associated with the feeding of polybrom-inated biphenyl-contaminated protein concentrate to dairy cattle. J Am Vet Med Assn 1974; 165: 437-9.
13. Constable JD, Hatch MC. Reproductive effects of herbicide exposure in Vietnam: recent studies by the Vietnamese and others. Terat Carcinogen Mutagen 1985; 5: 231-50.
14. Kashimoto T, Miyata H. Differences between Yusho and other kinds of poisoning involving only PCBs. In Waid JS ed. PCBs and The Environment. CRC Press, Boca Raton, FL, 1994.
15. Hoffman RE. Recent studies of the human immunotoxic effects of 2,3,7,8-tetrachloro dibenzo-p-dioxin. In Newcombe DS, Rose NR, Bloom JC eds. Clinical Immunotoxicology. Raven Press, New York, 1992, pp 339-348.
16. Colborn T, Clement C. Chemically-induced Alterations in Sexual and Functional Development: The Wildlife/Human Connection. Princeton Scientific Publishing, 1993.
17. Colborn T, Vom Saal FS, Soto AM. Developmental effects of endocrine-disruptive chemicals in wildlife and humans. Environ Health Perspect 1993; 101(5): 378-83.
18. Kelce WR, Monosson E, Gamcsik MP, Laws SC, Gray LE. Environmental hormone disrupters - evidence that vinclozolin developmental toxicity is mediated by antiandrogenic metabolites. Toxicol Appl Pharmacol 1994; 126(2): 276-85.
19. Brouwer A, Ahlborg UG, Vandenberg M, Birnbaum LS, Boersma ER, Bosveld B, Denison MS, Gray LE, Hagmar L, Holene E, Huisman M, Jacobson SW, Jacobson JL, Koopmanesseboom C, Koppe JG, Kulig BM, Morse DC, Muckle G, Peterson RE, Sauer PJJ, Seegal RF, Smitsvanprooije AE, Touwen BCL, Weisglaskuperus N, Winneke G. Functional aspects of developmental toxicity of polyhalogenated aromatic-hydrocarbons in experimental animals and human infants. Eur J Pharmacol Environ Toxicol Pharmacol 1995; 293(1): 1-40.
20. Guillette LJ, Pickford DB, Crain DA, Rooney AA, Percival HF. Reduction in penis size and plasma testerone concentrations in juvenile alligators living in a contaminated environment. Gen Comp Endocrinol 1996; 101(1): 32-42.
21. Laws SC, Ferrell JM, Stoker TE, Schmid J, Cooper RL. The effects of atrazine on female Wistar rats: An evlauation of the protocol for assessing prenatal development and thyroid function. Toxicol Sci 2000; 58: 366-76.
22. Hokanson R, Hanneman W, Hennessey M, Connelly, K, McDonald T, Chowdhary R, and Busbee D. DEHP, bis(2)-ethylhexyl phthalate, alters gene expression in human cells: possible correlation with initiation of fetal developmental abnormalities. Human Experimental Toxicology 2006; 25: 119-27.
23. Maxwell PH, Wiesener MS, Chang G-W, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher, ER, Ratcliffe PJ. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 1999; 399: 271-5.
24. Sutter CH, Laughner E, Semenza GL. Hypoxia-inducible factor 1-alpha protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations. Proc Nat Acad Sci 2000; 97: 4748-53.
25. Bruick RK. Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia. Proc Nat Acad Sci 2000; 97: 9082-87.
26. Semenza GL, Rue EA, Iyer NV, Pang MG, Kearns WG. Assignment of the hypoxia-inducible factor 1-alpha gene to a region of conserved synteny on mouse chromosome 12 and human chromosome 14q. Genomics 1996; 34: 437-9.
27. Koshiji M, To K, K-W, Hammer S, Kumamoto K, Harris AL, Modrich P, Huang LE. HIF-1-alpha induces genetic instability by transcriptionally downregulating MutS-alpha expression. Molec Cell 2005; 17: 793-803.
28. Gustafsson MV, Zheng X, Pereira T, Gradin K, Jin S, Lundkvist J, Ruas JL, Poellinger L, Lendahl U, Bondesson M. Hypoxia requires Notch signaling to maintain the undifferentiated cell state. Dev. Cell 2005; 9: 617-28.
29. Bleul CC, Farzan M, Choe H, Parolin C, Clark-Lewis I, Sodroski J, Springer TA. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 1996; 382: 829-33.
30. Zhang K, McQuibban GA, Silva C, Butler GS, Johnston JB, Holden J, Clark-Lewis I, Overall CM, Power C. HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration. Nature Neurosci 2003; 6: 1064-71.
31. Pablos JL, Santiago B, Galindo M, Torres C, Brehmer MT, Blanco FJ, Garcia-Lazaro FJ. Synoviocyte-derived CXCL12 is displayed on endothelium and induces angiogenesis in rheumatoid arthritis. J Immun 2003; 170: 2147-52.
32. Levesque J-P, Hendy J, Takamatsu Y, Simmons PJ, Bendall LJ. Disruption of the CXCR4/CXCL12 chemotactic interaction during hematopoietic stem cell mobilization induced by GCSF or cyclophosphamide. J Clin Invest 2003; 111: 187-96.
33. Butler JM, Guthrie SM, Koc M, Afzal A, Caballero S, Brooks HL, Mames RN, Segal MS, Grant MB, Scott EW. SDF-1 is both necessary and sufficient to promote proliferative retinopathy. J Clin Invest 2005; 115: 86-93.
34. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, MacDonald ME, Stuhlmann H, Koup RA, Landau NR. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996; 86: 367-77.
35. Huang R-P, Fan Y, de Belle I, Niemeyer C, Gottardis MM, Mercola D, Adamson ED. Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation. Int J Cancer 1997; 72: 102-9.
36. Liu H, Chao D, Nakayama EE, Taguchi H, Goto M, Xin X, Takamatsu J, Saito H, Ishikawa Y, Akaza T, Juji T, Takebe Y. Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Nat Acad Sci 1999; 96: 4581-85.
37. Fahmy RG, Dass CR, Sun L-Q, Chesterman CN, Khachigian LM. Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth. Nature Med 2003; 9: 1026-32.
38. Virolle T, Krones-Herzig A, Baron V, De Gregorio G, Adamson ED, Mercola D. Erg1 promotes growth and survival of prostate cancer cells: identification of novel Egr1 target genes. J Biol Chem 2003; 278: 11802-10.